2024 HCPCS Code C9076
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: lisocabtagene viable preparation leukapheresis autologous therapeutic million
Notice | HCPCS C9076 terminated on September 30, 2021. |
Short Description | Lisocabtagene car pos t |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | October 01, 2021 |
HCPCS Code Added Date | July 01, 2021 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 9 - Other medical items or services |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9058 - Injection,pegfilgrastim-bmez
- C9059 - Injection, meloxicam
- C9060 - Fluoroestradiol f18
- C9061 - Injection, teprotumumab-trbw
- C9062 - Daratumumab hyaluronidase
- C9063 - Injection, eptinezumab-jjmr
- C9064 - Mitomycin pyelocalyceal inst
- C9065 - Romidepsin non-lyophilized
- C9066 - Sacituzumab govitecan-hziy
- C9067 - Gallium ga-68 dotatoc
- C9068 - Copper cu-64, dotatate, dx
- C9069 - Belantamab mafodontin-blmf
- C9070 - Injection, tafasitamab-cxix
- C9071 - Injection, viltolarsen
- C9072 - Inj, imm glob asceniv
- C9073 - Brexucabtagene autoleucel ca
- C9074 - Injection, lumasiran
- C9075 - Injection, casimersen, 10 mg
- C9076 - Lisocabtagene car pos t
- C9077 - Inj cabotegravir/rilpivirine